Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Adjuvanted vaccines containing modified S1 Spike protein of SARS-CoV-2 variant C.1.2 for subcutaneous administration and methods of use

Adjuvanted vaccines containing modified S1 Spike protein of SARS-CoV-2 variant C.1.2 for subcutaneous administration and methods of use

US Patent 11911461 · Granted Feb 27, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified RSV F proteins and methods of their use2025
Recombinant bovine immunodeficiency virus-like particles comprising an influenza2025
Wash tool2023
Hydraulic low-torque valve conversion apparatus and method2023
Recombinant bovine immunodeficiency virus gag virus-like particles containing in2023
Non-electric explosive device and method of severing a tubular2022
Dissolving metal supports in 3D printed metals and ceramics using sensitization2022
Modified RSV F proteins and methods of their use2022
Subsea duplex pump, subsea pumping system, and subsea pumping method2022
Motion compensating floor system and method2022
Subsea flange tool2021
Portable firewall2021